Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 8994294)

  • 1. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
    Whiteley LO; Hudson L; Pretlow TP
    Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis.
    Caderni G; Giannini A; Lancioni L; Luceri C; Biggeri A; Dolara P
    Br J Cancer; 1995 Apr; 71(4):763-9. PubMed ID: 7710942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of azoxymethane-induced aberrant crypt foci in inbred mice.
    Delker DA; Wang QS; Papanikolaou A; Whiteley HE; Rosenberg DW
    Exp Mol Pathol; 1999 Feb; 65(3):141-9. PubMed ID: 10234360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected antagonistic action of 3,2'-dimethyl-4-aminobiphenyl on aberrant crypt induction by 1,2-dimethylhydrazine or azoxymethane in rat colon.
    Steffensen IL; Paulsen JE; Alexander J
    Carcinogenesis; 1995 Dec; 16(12):2981-8. PubMed ID: 8603473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
    Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
    Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen.
    Pretlow TP; O'Riordan MA; Spancake KM; Pretlow TG
    Am J Pathol; 1993 Jun; 142(6):1695-700. PubMed ID: 8506941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
    Rao CV; Kawamori T; Hamid R; Reddy BS
    Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions.
    Pretlow TP; O'Riordan MA; Pretlow TG; Stellato TA
    J Cell Biochem Suppl; 1992; 16G():55-62. PubMed ID: 1361589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats.
    Challa A; Rao DR; Chawan CB; Shackelford L
    Carcinogenesis; 1997 Mar; 18(3):517-21. PubMed ID: 9067551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive effect of 2-(allylthio)pyrazine (2-AP) on rat colon carcinogenesis induced by azoxymethane (AOM).
    Kim DJ; Kang JS; Ahn B; Kim KS; Park KH; Choi KS; Surh YJ; Kim ND
    Cancer Lett; 2001 May; 166(2):125-33. PubMed ID: 11311484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents.
    Pereira MA; Barnes LH; Rassman VL; Kelloff GV; Steele VE
    Carcinogenesis; 1994 May; 15(5):1049-54. PubMed ID: 8200067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate.
    Suzuki R; Miyamoto S; Yasui Y; Sugie S; Tanaka T
    BMC Cancer; 2007 May; 7():84. PubMed ID: 17506908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
    Femia AP; Dolara P; Caderni G
    Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
    Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
    Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon.
    Yamashita N; Minamoto T; Onda M; Esumi H
    Jpn J Cancer Res; 1994 Jul; 85(7):692-8. PubMed ID: 7915263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts.
    Baines AT; Holubec H; Basye JL; Thorne P; Bhattacharyya AK; Spallholz J; Shriver B; Cui H; Roe D; Clark LC; Earnest DL; Nelson MA
    Cancer Lett; 2000 Nov; 160(2):193-8. PubMed ID: 11053649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.